The Digital Pathology Journey

Recorded On: 09/30/2025

This presentation will outline Versant Diagnostics' journey and strategy in implementing digital pathology across its laboratory network. Key aspects to be covered include: •Versant's leadership in pathology: Highlighting our specialized focus, early adoption of digital technologies, industry recognition, unique subspecialty product lines, and expertise in serving large hospital systems. •Desired outcomes: Improved productivity, increased pathologist satisfaction (reducing burnout), facilitated recruitment, reduced turnaround times, greater diagnostic accuracy, and enhanced physician communication. •Versant's financial modeling: Demonstrating the anticipated financial benefits of the digital pathology initiative. •Tactical approach: Focusing on the selection of an Image Management System (IMS) that is interoperable with various scanners, LIS, and AI solutions, while ensuring business continuity and stability with input from our pathologists. •Validation process: Detailing the rigorous evaluation process for scanners, monitors, and the IMS platform. This presentation will provide a comprehensive overview of Versant's strategic approach to digital pathology, emphasizing its potential to enhance patient care and improve operational efficiency.

CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of registration.

Lola Leibensperger

Lola Leibensperger is the Assistant Vice President of Operations at Versant Diagnostics, where I oversee daily operations, develop strategic initiatives for digital pathology, and ensure regulatory compliance for multiple pathology sites and laboratories. With a strong background in laboratory medicine, I have held various roles, from a bench tech to Director-level positions, where I have successfully led teams.

Michele M. Robinson

Michele joined Dahl-Chase 23 years ago, bringing with her a foundation of clinical laboratory experience gained as a generalist in a small-town hospital setting. Initially hired as the evening shift supervisor, her responsibilities included HPV testing and work in the cytoprep laboratory. In 2007, after two years of managing the Histology department and completing rigorous training, Michele achieved HTL certification. Furthering her professional development, she earned an MBA with a concentration in Healthcare Management in 2017. In 2021, Michele assumed the role of Director of Clinical Operations at Dahl Chase.